RIBER DITTE,TOLBORG JAKOB LIND,HAMPRECHT DIETER WOLFGANG,RIST WOLFGANG
申请号：
AP2016009212
公开号：
AP2016009212A0
申请日:
2014.10.17
申请国别(地区):
AP
年份:
2016
代理人:
摘要：
The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel acylated glucagon analog peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.
